Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : The New QLogic (ANCR) -- Ignore unavailable to you. Want to Upgrade?

To: Roy Sardina who wrote (21107)	3/17/1999 7:45:00 AM
From: Nine_USA	Read Replies (2) \| Respond to of 29386

Roy, Your willingness in early Oct 1998 to pay more than Brocade's switch development cost in order to get Anchor is comforting to me. This was a very bad time in the markets and the technology market in particular. It also suggests that you held the Ancor product to be a viable competitor against Brocade and other switch makers.

To: Roy Sardina who wrote (21107)	3/17/1999 8:55:00 AM
From: doc	Read Replies (1) \| Respond to of 29386

roy, you made the statement "ancr could be bought for under $50 mil" on 30 oct. 98. the chart i've included clearly shows ancr in the $1.75 range at that time. one week later it was over $2 and a month later it was close to $4. exchange2000.com from the 3rd quarterly report ancr had close to 13mil shares. the poison pill was announced on 3 november 98. <<"The lawyers and bankers looked at the ANCR filings and determined that the investors ability to continue to issue shares made a significant transaction almost impossible. So we canned the idea and moved on". after all your contradicting statements. do you still stand by your statement that ancr could have been bought for under $50 mil?